Chief Accounting Officer
Baxter International Inc (BAX)Equibles does not estimate personal net worth.
Get an email with a short summary when Baxter International Inc publishes a filing, an earnings call transcript or a press release.
Get BAX alertsAnita Zielinski is recorded as CFO at Baxter International Inc (BAX) since March 16, 2026 and Chief Accounting Officer at Baxter International Inc (BAX) since February 21, 2025. Baxter International Inc reported in an 8-K filed August 4, 2026 that Anita Zielinski resigned as Senior Vice President, Chief Accounting Officer and Controller, effective September 15, 2026. Baxter International Inc reported in an 8-K filed August 4, 2026 that Anita Zielinski resigned as Interim Chief Financial Officer, effective September 15, 2026. Baxter International Inc reported in an 8-K filed March 16, 2026 that Anita Zielinski was appointed Interim Chief Financial Officer, effective March 16, 2026. Equibles holds 4 filed executive changes naming Anita Zielinski; each is listed under recent activity with its source filing. Anita Zielinski has spoken on 2 earnings calls across 1 company, most recently for Baxter International Inc on July 30, 2026. Baxter International Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Baxter International Inc includes Andrew Hider (CEO, CFO and Board Member), Brent Shafer (CEO and Chairman), José Almeida (CEO) and 7 others.
“On July 31, 2026, Anita Zielinski notified Baxter International Inc. (the “Company”) of her decision to resign as the Company’s Interim Chief Financial Officer and Senior Vice President, Chief Accounting Officer and Controller, effective as of September 15, 2026, to join another company.”
“On July 31, 2026, Anita Zielinski notified Baxter International Inc. (the “Company”) of her decision to resign as the Company’s Interim Chief Financial Officer and Senior Vice President, Chief Accounting Officer and Controller, effective as of September 15, 2026, to join another company.”
“I'm happy to be joining the call this morning to cover the details of Baxter's second quarter financial performance, as well as commentary on our updated outlook for the remainder of 2026.”
“I'm happy to be joining the call this morning to cover the details of Baxter's first quarter financial performance, as well as commentary in our outlook for the remainder of 2026.”
2026-03-16–present
2025-02-21–present
2025-02-21–2026-09-15
Start not stated–2026-09-15
Medical Instruments & Supplies · Healthcare
CFO, Chief Accounting Officer
2025-02-21–present
